comparison of magnesium sulfate and morphine sulfate in renal colic

Phase 2

Recruiting

• Conditions: renal colic; Renal and Urogenital - Other renal and urogenital disorders; Anaesthesiology - Pain management

• Registration Number: ACTRN12615001372572
• Lead Sponsor: Akram Zolfaghari Sadrabad

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-12-16
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

patients with renal colic with age of 18-55 years

Exclusion Criteria

renal failure, pregnancy, systolic blood pressure under 100mmhg, respiratory rate under 12 per minute, opium addict, heart failure, patients that are under treatment with magnesium sulfate

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of participants with at least a 3 point reduction in numeric pain scale.[15 minutes after drug administer]; the patients were evaluated for any side effects of M.S. and Mg.S. such as vomiting, nausea, low blood pressure, apnea, dizziness and light-headed.[15 minutes after drug administer]

Secondary Outcome Measures

Name	Time	Method
Proportion of participants with at least a 3 point reduction in numeric pain scale.[30minutes after drug administer]; the patients were evaluated for any side effects of M.S. and Mg.S. such as vomiting, nausea, low blood pressure, apnea, dizziness and light-headed.[30 minutes after drug administer]